Literature DB >> 11830420

HLA-DR4 and the spondyloarthropathies.

J D Taurog1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11830420      PMCID： PMC1754014          DOI： 10.1136/ard.61.3.193

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  15 in total

Review 1.  Ankylosing spondylitis--at the interface of bone and cartilage.

Authors:  W P Maksymowych
Journal:  J Rheumatol       Date:  2000-10       Impact factor: 4.666

Review 2.  Enthesitis, osteitis, microbes, biomechanics, and immune reactivity in ankylosing spondylitis.

Authors:  D McGonagle; P Emery
Journal:  J Rheumatol       Date:  2000-10       Impact factor: 4.666

3.  Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.

Authors:  F Van den Bosch; E Kruithof; D Baeten; F De Keyser; H Mielants; E M Veys
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

4.  Is rheumatoid spondylitis a separate entity?

Authors:  W GRAHAM
Journal:  Arthritis Rheum       Date:  1960-02

Review 5.  Radiologic diagnosis and pathology of the spondyloarthropathies.

Authors:  J Braun; M Bollow; J Sieper
Journal:  Rheum Dis Clin North Am       Date:  1998-11       Impact factor: 2.670

Review 6.  Major histocompatibility complex-directed susceptibility to rheumatoid arthritis.

Authors:  G T Nepom
Journal:  Adv Immunol       Date:  1998       Impact factor: 3.543

7.  The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies.

Authors:  R Said-Nahal; C Miceli-Richard; J M Berthelot; A Duché; E Dernis-Labous; G Le Blévec; A Saraux; A Perdriger; S Guis; P Claudepierre; J Sibilia; B Amor; M Dougados; M Breban
Journal:  Arthritis Rheum       Date:  2000-06

8.  Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab.

Authors:  J Brandt; H Haibel; D Cornely; W Golder; J Gonzalez; J Reddig; W Thriene; J Sieper; J Braun
Journal:  Arthritis Rheum       Date:  2000-06

9.  Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study.

Authors:  H Marzo-Ortega; D McGonagle; P O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2001-09

10.  The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families.

Authors:  R Said-Nahal; C Miceli-Richard; C Gautreau; R Tamouza; N Borot; R Porcher; D Charron; M Dougados; M Breban
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103
View more
  1 in total

Review 1.  HLA-B27 misfolding and spondyloarthropathies.

Authors:  Robert A Colbert; Monica L DeLay; Gerlinde Layh-Schmitt; Dawn P Sowders
Journal:  Prion       Date:  2009-01-03       Impact factor: 3.931
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.